![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | KBTBD2 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KBTBD2 mRNA | CTD | PMID:22079256 | KBTBD2 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of KBTBD2 mRNA | CTD | PMID:22206623 | KBTBD2 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Kbtbd2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of KBTBD2 mRNA] | CTD | PMID:22206623 | KBTBD2 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Kbtbd2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KBTBD2 mRNA | CTD | PMID:17942748 | KBTBD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Kbtbd2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KBTBD2 mRNA | CTD | PMID:17942748 | KBTBD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KBTBD2 mRNA | CTD | PMID:33387578 | KBTBD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of KBTBD2 mRNA | CTD | PMID:21570461 | KBTBD2 | Human | 2,4-dinitrotoluene | affects expression | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of KBTBD2 mRNA | CTD | PMID:21346803 | KBTBD2 | Human | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of KBTBD2 mRNA | CTD | PMID:30851411 | KBTBD2 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of KBTBD2 protein | CTD | PMID:34915118 | KBTBD2 | Human | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of KBTBD2 mRNA | CTD | PMID:18648102 | KBTBD2 | Human | afimoxifene | increases expression | EXP | | 6480464 | afimoxifene results in increased expression of KBTBD2 mRNA | CTD | PMID:16849584 | KBTBD2 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of KBTBD2 mRNA | CTD | PMID:24449571 | KBTBD2 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to KBTBD2 mRNA] | CTD | PMID:32406909 | KBTBD2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of KBTBD2 5' UTR | CTD | PMID:27901495 | KBTBD2 | Human | cadmium dichloride | increases expression | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of KBTBD2 mRNA | CTD | PMID:19010381 | KBTBD2 | Human | chlorpyrifos | decreases expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of KBTBD2 mRNA | CTD | PMID:37019170 | KBTBD2 | Human | copper atom | increases expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | Copper results in increased expression of KBTBD2 mRNA | CTD | PMID:16629173 | KBTBD2 | Human | copper(0) | increases expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | Copper results in increased expression of KBTBD2 mRNA | CTD | PMID:16629173 | KBTBD2 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of KBTBD2 mRNA | CTD | PMID:37042841 | KBTBD2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | KBTBD2 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of KBTBD2 mRNA | CTD | PMID:29803840 | KBTBD2 | Human | ethanol | affects splicing | ISO | Kbtbd2 (Mus musculus) | 6480464 | Ethanol affects the splicing of KBTBD2 mRNA | CTD | PMID:30319688 | KBTBD2 | Human | fluoranthene | multiple interactions | ISO | Kbtbd2 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of KBTBD2 mRNA | CTD | PMID:28329830 | KBTBD2 | Human | folic acid | multiple interactions | ISO | Kbtbd2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of KBTBD2 mRNA] | CTD | PMID:22206623 | KBTBD2 | Human | furan | increases methylation | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | furan results in increased methylation of KBTBD2 gene | CTD | PMID:22079235 | KBTBD2 | Human | geldanamycin | increases expression | EXP | | 6480464 | geldanamycin results in increased expression of KBTBD2 mRNA | CTD | PMID:26705709 | KBTBD2 | Human | gentamycin | increases expression | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of KBTBD2 mRNA | CTD | PMID:22061828 | KBTBD2 | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of KBTBD2 mRNA | CTD | PMID:28988120 | KBTBD2 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of KBTBD2 mRNA | CTD | PMID:28001369 | KBTBD2 | Human | paracetamol | affects expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of KBTBD2 mRNA | CTD | PMID:17562736 | KBTBD2 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KBTBD2 mRNA | CTD | PMID:22079256 | KBTBD2 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of KBTBD2 mRNA | CTD | PMID:22079256 | KBTBD2 | Human | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of KBTBD2 mRNA | CTD | PMID:30851411 | KBTBD2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of KBTBD2 mRNA | CTD | PMID:23557933 | KBTBD2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | KBTBD2 | Human | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of KBTBD2 mRNA | CTD | PMID:27188386 | KBTBD2 | Human | thioacetamide | increases expression | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of KBTBD2 mRNA | CTD | PMID:23411599 and PMID:34492290 | KBTBD2 | Human | titanium dioxide | increases methylation | ISO | Kbtbd2 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of KBTBD2 gene | CTD | PMID:35295148 | KBTBD2 | Human | toxaphene | decreases expression | ISO | Kbtbd2 (Rattus norvegicus) | 6480464 | Toxaphene results in decreased expression of KBTBD2 mRNA | CTD | PMID:23153324 | KBTBD2 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of KBTBD2 mRNA | CTD | PMID:26272509 | KBTBD2 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of KBTBD2 mRNA | CTD | PMID:28542535 | KBTBD2 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KBTBD2 mRNA | CTD | PMID:27188386 | KBTBD2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of KBTBD2 mRNA | CTD | PMID:37042841 | KBTBD2 | Human | triptonide | increases expression | ISO | Kbtbd2 (Mus musculus) | 6480464 | triptonide results in increased expression of KBTBD2 mRNA | CTD | PMID:33045310 | KBTBD2 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of KBTBD2 mRNA | CTD | PMID:28818685 | KBTBD2 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of KBTBD2 gene | CTD | PMID:29154799 | KBTBD2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of KBTBD2 mRNA | CTD | PMID:19101580 more ... | KBTBD2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KBTBD2 mRNA | CTD | PMID:27188386 | KBTBD2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of KBTBD2 mRNA | CTD | PMID:25979313 | KBTBD2 | Human | vitamin E | increases expression | EXP | | 6480464 | Vitamin E results in increased expression of KBTBD2 mRNA | CTD | PMID:19244175 | KBTBD2 | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of KBTBD2 mRNA | CTD | PMID:27188386 | KBTBD2 | Human | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of KBTBD2 mRNA | CTD | PMID:18593933 | KBTBD2 | Human | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of KBTBD2 mRNA | CTD | PMID:18593933 | KBTBD2 | Human | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of KBTBD2 mRNA | CTD | PMID:20977926 | |